论文部分内容阅读
目的：分析输血前不规则抗体筛查结果,并探析其临床意义。方法本院自2014年起在输血前进行不规则抗体筛查,将2014年1月～12月412例进行输血前不规则抗体筛查者作为实验组。以此前2013年1月～12月396例未进行输血前不规则抗体筛查者作为对照组。结果数据经过统计学分析发现,412例患者共检出不规则抗体6例,检出率为1.46%。实验组输血不良反应发生率明显低于对照组,组间有显著的统计学差异(<0.05)。结论输血前不规则抗体筛查可及时发现患者体内的不规则抗体,有利于保证输血安全性,应将其作为输血前的常规检查项目。“,”Objective Analyze the screening results of irregular antibodies before blood transfusion,and analyze its clinical significance.Methods In the hospital carry out irregular antibody screening from 2014,will be Jan.to Dec.2014,412 cases of irregular antibody screening before blood transfusion as experimental group.Before Jan.to Dec.2013,396 cases of irregular antibody screening before blood transfusion were used as control group.Results There were 6 cases of irregular antibodies in 412 cases,the detection rate was 1.46%.The incidence of adverse reactions in experimental group was significantly lower than control group( <0.05).Conclusion Irregular antibody screening in patients with blood transfusion can be found in time to ensure the safety of blood transfusion.